All News

04-15 Cigna Healthcare Once Again Recognized for Industry Leading Digital Experience by JD Power PR
04-15 Baird Adjusts Cigna Price Target to $306 From $315, Maintains Outperform Rating MT
04-09 PBM's Under Regulatory Attack-Blockchain Upstart WGRX Belongs on Investor's Radar AQ
04-02 The Cigna Group's First Quarter 2026 Earnings Release Details PR
03-24 The Cigna Group Foundation Supports More Than 8,000 Veterans Through Community-Led Housing Stability Programs PR
03-23 Cigna : Appoints New Chief Medical Officer for Cigna Healthcare PU
03-18 The Cigna Group Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 01:50 PM
03-13 Cigna : Notice of 2026 Annual Meeting and Proxy Statement PU
03-12 Quest Diagnostics Incorporated Appoints Timothy Wentworth as Director CI
03-12 Cigna Shares Rise After Bernstein Upgrade MT
03-12 Bernstein Upgrades Cigna to Outperform From Market Perform, Adjusts Price Target to $358 From $307 MT
03-12 US insurers and hospitals turn to new AI for age-old battle over charges vs payments RE
03-04 FA
03-04 AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries BU
03-03 Health Care Losses Limited Amid Defensive Bias - Health Care Roundup DJ
03-03 Cigna Names Brian Evanko CEO as David Cordani Retires -- Update DJ
03-03 Analyst recommendations: Amazon, Paramount, Pinterest, Cigna, Tesla… Zonebourse
03-03 The Cigna Group Announces Brian Evanko's Election to Board of Directors and David M. Cordani's Transition to Executive Chair CI
03-03 The Cigna Group Announces Chief Executive Officer Changes, Effective July 1, 2026 CI
03-03 From Calm to Caution Zonebourse
03-03 Cigna insider Brian Evanko to succeed retiring CEO David Cordani RE
03-03 Cigna Names Brian Evanko CEO as David Cordani Retires DJ
03-03 Cigna CEO David Cordani to Retire; COO Brian Evanko Named Successor MT
03-03 The Cigna Group announces president & COO Brian Evanko to succeed David M. Cordani as chief executive officer RE
03-03 Cigna president & COO Brian Evanko to succeed David Cordani as CEO; shares down 3.7% premarket RE
No results for this search